214 related articles for article (PubMed ID: 29988738)
41. Overexpression of epithelial cell transforming 2 protein in colorectal carcinoma predicts a poor prognosis.
Li Y; Cai X; Chen B; Gu H; Liu C
Exp Ther Med; 2017 Nov; 14(5):4862-4868. PubMed ID: 29109759
[TBL] [Abstract][Full Text] [Related]
42. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients.
Dimitriou N; Felekouras E; Karavokyros I; Alexandrou A; Pikoulis E; Griniatsos J
BMC Cancer; 2018 Dec; 18(1):1202. PubMed ID: 30509242
[TBL] [Abstract][Full Text] [Related]
43. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
44. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
45. Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression.
Chang YC; Chan YC; Chang WM; Lin YF; Yang CJ; Su CY; Huang MS; Wu ATH; Hsiao M
Cancer Lett; 2017 Sep; 403():28-36. PubMed ID: 28610954
[TBL] [Abstract][Full Text] [Related]
46. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
[TBL] [Abstract][Full Text] [Related]
47. Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
Han S; Huang T; Li W; Liu S; Yang W; Shi Q; Li H; Ren J; Hou F
Cell Physiol Biochem; 2018; 48(2):516-527. PubMed ID: 30021192
[TBL] [Abstract][Full Text] [Related]
48. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
[TBL] [Abstract][Full Text] [Related]
49. RNA helicase DEAD box protein 5 regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA function in hepatitis B virus infection and hepatocarcinogenesis.
Zhang H; Xing Z; Mani SK; Bancel B; Durantel D; Zoulim F; Tran EJ; Merle P; Andrisani O
Hepatology; 2016 Oct; 64(4):1033-48. PubMed ID: 27338022
[TBL] [Abstract][Full Text] [Related]
50. CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study.
Huang F; Peng Y; Ye Q; Chen J; Li Y; Liu S; Xu Y; Huang L
World J Surg Oncol; 2020 Oct; 18(1):274. PubMed ID: 33099318
[TBL] [Abstract][Full Text] [Related]
51. Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer.
Fan XJ; Wan XB; Fu XH; Wu PH; Chen DK; Wang PN; Jiang L; Wang DH; Chen ZT; Huang Y; Wang JP; Wang L
Tumour Biol; 2014 Oct; 35(10):10487-95. PubMed ID: 25056534
[TBL] [Abstract][Full Text] [Related]
52. Twist2 is a valuable prognostic biomarker for colorectal cancer.
Yu H; Jin GZ; Liu K; Dong H; Yu H; Duan JC; Li Z; Dong W; Cong WM; Yang JH
World J Gastroenterol; 2013 Apr; 19(15):2404-11. PubMed ID: 23613636
[TBL] [Abstract][Full Text] [Related]
53. Multiple functions of the DEAD-box RNA helicase, DDX5 (p68), make DDX5 a superior oncogenic biomarker and target for targeted cancer therapy.
Li F; Fountzilas C; Puzanov I; Attwood KM; Morrison C; Ling X
Am J Cancer Res; 2021; 11(10):5190-5213. PubMed ID: 34765320
[TBL] [Abstract][Full Text] [Related]
54. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
55. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
Gaber A; Nodin B; Hotakainen K; Nilsson E; Stenman UH; Bjartell A; Birgisson H; Jirström K
BMC Cancer; 2010 Sep; 10():498. PubMed ID: 20849596
[TBL] [Abstract][Full Text] [Related]
56. Prognostic Value of E-cadherin-, CD44-, and MSH2-associated Nomograms in Patients With Stage II and III Colorectal Cancer.
Qu J; Jiang Y; Liu H; Deng H; Yu J; Qi X; Ge W; Li G
Transl Oncol; 2017 Apr; 10(2):121-131. PubMed ID: 28126685
[TBL] [Abstract][Full Text] [Related]
57. Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer.
Xiao X; Wang L; Wei P; Chi Y; Li D; Wang Q; Ni S; Tan C; Sheng W; Sun M; Zhou X; Du X
J Transl Med; 2013 Jun; 11():151. PubMed ID: 23787019
[TBL] [Abstract][Full Text] [Related]
58. Nomograms for predicting prognostic value of inflammatory biomarkers in colorectal cancer patients after radical resection.
Li Y; Jia H; Yu W; Xu Y; Li X; Li Q; Cai S
Int J Cancer; 2016 Jul; 139(1):220-31. PubMed ID: 26933932
[TBL] [Abstract][Full Text] [Related]
59. New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer.
Peng Y; Li X; Wu M; Yang J; Liu M; Zhang W; Xiang B; Wang X; Li X; Li G; Shen S
Mol Biosyst; 2012 Nov; 8(11):3077-88. PubMed ID: 22996014
[TBL] [Abstract][Full Text] [Related]
60. Role of the DEAD-box RNA helicase DDX5 (p68) in cancer DNA repair, immune suppression, cancer metabolic control, virus infection promotion, and human microbiome (microbiota) negative influence.
Li F; Ling X; Chakraborty S; Fountzilas C; Wang J; Jamroze A; Liu X; Kalinski P; Tang DG
J Exp Clin Cancer Res; 2023 Aug; 42(1):213. PubMed ID: 37596619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
